Home › Pancreatic Ductal Carcinoma › Ohio
Pancreatic Ductal Carcinoma clinical trials in Ohio
3 studies for Pancreatic Ductal Carcinoma are looking for participants at sites in Ohio.
Cities in Ohio
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
- Site 13, Cincinnati
- Site 20, Toledo
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07259317Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- University of Cincinnati Medical Center, Cincinnati
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT06445062Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Christ Hospital Cancer Center, Cincinnati
- Taylor Cancer Research Center, Maumee
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated May 15, 2026 · NCT05379985From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.